1. Could you please provide the total number of patients with any treatment in the last three months for?
a. Total non-small cell lung cancer (NSCLC)
b. BRAF+ non-small cell lung cancer (NSCLC)
2. In the past 3 months, how many non-small cell lung cancer (NSCLC) patients were treated with?
a. Afatinib
b. Alectinib
c. Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel
d. Atezolizumab monotherapy
e. Bevacizumab
f. Brigatinib
g. Ceritinib
h. Crizotinib
i. Dacomitinib
j. Dabrafenib with Trametinib
k. Docetaxel monotherapy
l. Durvalumab
m. Erlotinib
n. Gefitinib
o. Gemcitabine
p. Nintedanib with Docetaxel
q. Nivolumab
r. Osimertinib
s. Paclitaxel
t. Pembrolizumab chemo in combination
u. Pembrolizumab monotherapy
v. Pemetrexed with Carboplatin
w. Pemetrexed with Cisplatin
x. Vinorelbine and cisplatin/carboplatin

Download response Non-small cell lung cancer (NSCLC). 180221